Yale University: Carcinoma trials
The registry lists 13 Carcinoma studies with Yale University as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 4Phase 2 5Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCCTerminatedNCT05776875Phase 2Results posted
- APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell CarcinomaCompletedNCT03502330Phase 1Results posted
- Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In SituCompletedNCT02908178Results posted
- Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular CarcinomaCompletedNCT02007954Phase 2Results posted
- Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs SurgeryCompletedNCT01298167Not applicableResults posted
- Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular CarcinomaCompletedNCT00844883Phase 2Results posted
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder CarcinomaCompletedNCT00461851Phase 2Results posted
- Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint InhibitorWithdrawnNCT04179110Phase 2
- Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCCWithdrawnNCT02686008Phase 1
- Window Trial 5-aza in HNSCC, T-tareCompletedNCT02178072Phase 1
- A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in SituCompletedNCT01628536Not applicable
- Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1
- Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002507Phase 3